This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Lyme disease vaccine history and current status
The Lyme vaccines LYMErix and ImuLyme faced safety and efficacy concerns. LYMErix was on the market 1998 to 2002 with about 75 percent effectiveness and notable local and systemic side effects. arthritis fears led to lawsuits and production stop. ImuLyme was never licensed. A canine vaccine exists and a Baxter human vaccine is in Europe with the antigen tied to arthritis removed. no widely used human vaccine is available yet.
MENTIONED IN THIS ARTICLE
Dr. Roach
California
GlaxoSmithKline
U.S
Pasteur
Baxter
Europe